Cosimo De Nunzio

Pubblicazioni

Titolo Pubblicato in Anno
Post-Voided Residual Ratio Does Not Predict Trifecta Outcome after Transurethral Resection of Prostate LIFE 2024
Benign Prostatic Hyperplasia Surgery: A Snapshot of Trends, Costs, and Surgical Retreatment Rates in the USA EUROPEAN UROLOGY FOCUS 2024
Trends and Costs of Minimally Invasive Surgery for Kidney Cancer in the US: A Population-based Study UROLOGY 2024
Letter to the Editor on "Predictors of Early Continence after Single-Port Transvesical Robot-Assisted Radical Prostatectomy" UROLOGY 2024
Summary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms EUROPEAN UROLOGY 2024
Prostatectomy in oligometastatic prostate cancer: a call for high-quality evidence PROSTATE CANCER AND PROSTATIC DISEASES 2024
Benign prostatic hyperplasia during active surveillance for prostate cancer: is it time to define management strategies? PROSTATE CANCER AND PROSTATIC DISEASES 2024
Open versus Minimally Invasive Nephroureterectomy: Contemporary Analysis from a Wide National Population-Based Database ANNALS OF SURGICAL ONCOLOGY 2024
Trimodal therapy vs radical cystectomy in patients with muscle-invasive bladder cancer: a systematic review and meta-analysis of comparative studies BJU INTERNATIONAL 2024
Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH PROSTATE CANCER AND PROSTATIC DISEASES 2024
Antibiotic prophylaxis in invasive urodynamics, a Delphi consensus of the Italian Society of Urodynamics (SIUD) NEUROUROLOGY AND URODYNAMICS 2024
The times have changed. Let the urologists change! PROSTATE CANCER AND PROSTATIC DISEASES 2024
Re: James P. Buteau, Daniel Moon, Michael T. Fahey, et al. Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.11.008 EUROPEAN UROLOGY ONCOLOGY 2024
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer PROSTATE CANCER AND PROSTATIC DISEASES 2024
Treatment preferences of patients with erectile dysfunction: a systematic review of randomized controlled trials MINERVA UROLOGY AND NEPHROLOGY 2024
Postoperative urinary incontinence following BPH surgery: insights from a comprehensive national database analysis MINERVA UROLOGY AND NEPHROLOGY 2024
Robot-assisted inguinal lymphadenectomy to treat penile and vulvar cancers: a scoping review MINERVA UROLOGY AND NEPHROLOGY 2024
Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-Vigilance database MINERVA UROLOGY AND NEPHROLOGY 2024
Minimally Invasive Adrenalectomy: A Population-Based Analysis of Contemporary Trends, Outcomes, Costs, and Impact of Social Determinants of Health UROLOGY PRACTICE 2024
Letter: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone‒Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist THE JOURNAL OF UROLOGY 2024

ERC

  • LS4_9
  • LS4_12
  • LS7
  • LS7_1
  • LS7_6

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Urology, prostate cancer, benign prostatic hyperplasia, Urodynamic, uro-oncology, minimally invasive treatment, laparoscopic and robotic

Keywords

urology
benign prostate hyperplasia
Castration-resistant prostate cancer
urodynamic testing
kidney calculi
kidney cancer
#bladder cancer
metabolic disorders
Risk factor for prostate cancer
Minimally invasive endoscopic surgery

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma